Suchergebnisse - "Szántó, Kata"

PubPharm (39)

1

Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases

enthalten in: Journal of Crohn's & colitis | 2024

von Jójárt, B. | Resál, T. | Kata, D. | +10

2

Conception and reality : Outcome of SARS-CoV-2 infection and vaccination among Hungarian IBD patients on biologic treatments

enthalten in: Vaccine: X | 2023

von Resál, T. | Matuz, M. | Keresztes, C. | +13

3

Nationwide experiences with trough levels, durability, and disease activity among inflammatory bowel disease patients following COVID-19 vaccination

enthalten in: Therapeutic advances in gastroenterology | 2023

von Resál, T. | Bacsur, P. | Horváth, M. | +10

4

Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone

enthalten in: Expert opinion on drug safety | 2023

von Resál, T. | Mangó, K. | Bacsur, P. | +12

5

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls

enthalten in: Therapeutic advances in gastroenterology | 2023

von Bacsur, P. | Rutka, M. | Asbóth, A. | +15

6

Psychological characteristics of patients with inflammatory bowel disease during the first wave of COVID-19

enthalten in: Przeglad gastroenterologiczny | 2023

von Dávid, A. | Szántó, K. | Fábián, A. | +7

7

Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease : Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Pauwels, R. | van der Woude, C. | Nieboer, D. | +55

CommentIn: Clin Gastroenterol Hepatol. 2022 Aug;20(8):1668-1670. - PMID 34058414

8

Effect of COVID-19 pandemic on workflows and infection prevention strategies of endoscopy units in Hungary - a cross-sectional survey

enthalten in: ResearchSquare.com | 2022

von Bor, R. | Szántó, K. | Fábián, A. | +9

9

Ustekinumab is associated with superior treatment persistence but not with higher remission rates versus vedolizumab in patients with refractory Crohn's disease : results from a multicentre cohort study

enthalten in: Therapeutic advances in gastroenterology | 2022

von Bacsur, P. | Matuz, M. | Resál, T. | +14

10

Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab - A prospective, multicenter cohort from Hungary

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2022

von Gonczi, L. | Szanto, K. | Farkas, K. | +18